Find therapies in clinical trials near you – page 71

Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Study of MK-7684A with Chemoradiotherapy Compared to Chemoradiotherapy with Durvalumab for Patients with Stage III Non-Small Cell Lung Cancer

Study of MK-7684A with Chemoradiotherapy Compared to Chemoradiotherapy with Durvalumab for Patients with Stage III Non-Small Cell Lung Cancer

Study on Zetomipzomib for Patients with Active Lupus Nephritis

Study on Zetomipzomib for Patients with Active Lupus Nephritis

Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma

Study of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma

Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer

Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

Study of LY3502970 for Adults with Obesity or Overweight and Type 2 Diabetes

Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

Study of Upadacitinib and Topical Corticosteroids for Adolescents and Adults with Moderate to Severe Eczema

Study of Belzutifan for Patients with Advanced Kidney Cancer

Study of Belzutifan for Patients with Advanced Kidney Cancer

Study on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)

Study on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)

Study of PF-06823859 for Adults with Active Cutaneous or Systemic Lupus Erythematosus with Skin Symptoms

Study of PF-06823859 for Adults with Active Cutaneous or Systemic Lupus Erythematosus with Skin Symptoms